long acting psychedelic analogues (Mindset Pharma)

长效迷幻药 (Mindset Pharma)

Report date: 2024/01/11 11:16:00
NME

Base Information

Drug Namelong acting psychedelic analogues (Mindset Pharma)
Drug Alias NameMSP-3002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMindset Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka America Inc
Inactive CompaniesN/A
Active IndicationsMental DisordersNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A